News of the WeekBiotechnology

Reaction to Stem Cells: A Tale of the Ticker

See allHide authors and affiliations

Science  13 Nov 1998:
Vol. 282, Issue 5392, pp. 1239
DOI: 10.1126/science.282.5392.1239a

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Geron Corp. of Menlo Park, California, saw its stock price jump when company-supported researchers reported in Science and the Proceedings of the National Academy of Sciences that they have cultured "immortal" stem cells in the laboratory (Science, 6 November, pp. 1014 and 1145). The cells could potentially be used to repair damaged organs and tissues. But the price soon sank as investors realized that the scientifically interesting findings wouldn't soon lead to profitable products.